Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tenon Medical, Inc. (TNON : NSDQ)

• Company Description    Tenon Medical Inc. is a medical device company which developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system for sacroiliac joint fixation/fusion surgery. Tenon Medical Inc. is based in LOS GATOS, CA. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $1.18 Daily Weekly Monthly 20 Day Moving Average: 1,027,775 shares Shares Outstanding: 8.88 (millions) Market Capitalization: $10.48 (millions) Beta: 1.28 52 Week High: $5.85 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.67% -2.28% 12 Week -29.34% -32.77% Year To Date -37.23% -45.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 104 COOPER COURT - LOS GATOS,CA 95032 USA ph: 408-649-5760 fax: - tenon@mzgroup.us http://www.tenonmed.com

• General Corporate Information    Officers Steven M. Foster - Chief Executive Officer; President and Director Richard Ferrari - Executive Chairman Kevin Williamson - Chief Financial Officer Richard Ginn - Chief Technology Officer and Director Ivan Howard - Director Peer Information Tenon Medical, Inc. (ABMD) Tenon Medical, Inc. (DMDS) Tenon Medical, Inc. (CPWY.) Tenon Medical, Inc. (EQUR) Tenon Medical, Inc. (ECIA) Tenon Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 88066N303 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 8.88 Most Recent Split Date: 9.00 (0.13:1) Beta: 1.28 Market Capitalization: $10.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.02 Price/Cash Flow: - Price / Sales: 3.56 EPS Growth vs. Year Ago Period: 95.59% vs. Previous Quarter: 64.36% Sales Growth vs. Year Ago Period: -37.40% vs. Previous Quarter: -22.31% ROE 09/30/25 - - 06/30/25 - -332.11 03/31/25 - -558.92 ROA 09/30/25 - - 06/30/25 - -106.82 03/31/25 - -129.73 Current Ratio 09/30/25 - - 06/30/25 - 3.86 03/31/25 - 5.46 Quick Ratio 09/30/25 - - 06/30/25 - 3.59 03/31/25 - 5.19 Operating Margin 09/30/25 - - 06/30/25 - -429.45 03/31/25 - -417.57 Net Margin 09/30/25 - - 06/30/25 - -429.45 03/31/25 - -417.57 Pre-Tax Margin 09/30/25 - - 06/30/25 - -429.45 03/31/25 - -417.57 Book Value 09/30/25 - - 06/30/25 - 0.39 03/31/25 - 0.91 Inventory Turnover 09/30/25 - - 06/30/25 - 2.56 03/31/25 - 2.83 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©